CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Revenues
Operating expenses
Research and development expense	121,162	159,095
General and administrative expense	544,767	362,124
Total operating expenses	665,929	521,219
Loss from operations	(665,929)	(521,219)
Other income (expense)
Financing costs	(142,730)	(30,500)
Interest expense	(48,634)	(30,583)
Loss on settlement of liabilities, net		(30,015)
Net loss	$ (857,293)	$ (612,317)
Net loss per share
Basic and diluted loss per common share (in Dollars per share)	$ 0.00	$ 0.00
Weighted average shares used to compute net loss per share
Basic and diluted weighted average common shares outstanding (in Shares)	813,637,211	517,885,384